2006 Updates Clinical Practice Guidelines and Recommendations

More documents

Recommendations

Info

Hemodialysis Adequacy Tables Table 1. Validated GFR-Estimating Equations . . . . . . . . . . . . . . . . . . . . . . . . . . . 17 Table 2. Causes of Unusually Low or High Endogenous Creatinine Generation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18 Table 3. Causes of Unusually Low or High Kidney Tubular Creatinine Secretion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19 Table 4. Methods for Calculating eKt/V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27 Table 4A. Preferred Measures of the Delivered Dose (in Order of Preference) . . 29 Table 5. Recommended Predialysis Blood-Drawing Procedure . . . . . . . . . . . . . 32 Table 6. Slow-Blood-Flow Method for Obtaining the Postdialysis Sample . . . . . 33 Table 7. Stop-Dialysate-Flow Method of Obtaining the Postdialysis Sample . . . . 34 Table 8. Effect of HD Dose on Mortality . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39 Table 9. Fraction of Treatments With an spKt/V Greater Than 1.2 When Targeting 1.2 to 1.4 per Dialysis . . . . . . . . . . . . . . . . . . . . . . . . . 40 Table 10. Effect of Residual Kidney Function on Mortality . . . . . . . . . . . . . . . . . . 52 Table 11. Complications That May Prompt Initiation of Kidney Replacement Therapy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 61 Table 12. Effect of High Flux Dialysis on Mortality, Cardiovascular . . . . . . . . . . . 70 Mortality and �2 Microglobulin (�2M) Table 13. Minimum spKt/V Values Corresponding to a stdKt/V of Approximately 2.0 per Week . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 73 Table 14. Effect of Dialyzer Reuse on Mortality . . . . . . . . . . . . . . . . . . . . . . . . . . 81 Table 15. Efforts to Protect RKF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 87 Table 16. Potential Insults to RKF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 88 Table 17. Effect of Pharmacologic Interventions on Loss of Residual Kidney Function . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 89 Table 18. Values for k at Different Dialysis Frequencies and BUN Targets . . . . . . 98 Table 19. Minimum spKt/V Required to Achieve a stdKt/V of 2.0 per Week . . . . 98 4 National Kidney Foundation KDOQI
Hemodialysis Adequacy Figures Figure 1. Impact of Ultrafiltration on Delivered Dose of HD Measured By Using spKt/V and URR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 26 Figure 2. eKt/V as a Function of Dialysis Treatment Time . . . . . . . . . . . . . . . . . . 27 Figure 3. Components of Postdialysis Urea (BUN) Rebound . . . . . . . . . . . . . . . . 32 Figure 4. Stop-dialysate Method for Postdialysis Blood Sampling . . . . . . . . . . . . . 35 Figure 5. Illustration of the “Lag Phenomenon” . . . . . . . . . . . . . . . . . . . . . . . . . . 44 Figure 6. Effect of Residual Native Kidney Clearance (Kr) . . . . . . . . . . . . . . . . . . 97 KDOQI National Kidney Foundation 5
Page 1 and 2: 2006 Updates Clinical Practice Guid
Page 3 and 4: KDOQI Advisory Board Members . . .
Page 5 and 6: Glossary . . . . . . . . . . . . .
Page 7: HEMODIALYSIS ADEQUACY
Page 12 and 13: Hemodialysis Adequacy Acronyms and
Page 14 and 15: td Time from beginning to end of di
Page 16 and 17: purpose unless it is implemented an
Page 18 and 19: metabolites that are known to accum
Page 20 and 21: etween concentration and clearance.
Page 22: VASCULAR ACCESS
Page 26 and 27: Vascular Access Tables Table 1. Pat
Page 28 and 29: Vascular Access Acronyms and Abbrev
Page 30 and 31: RR Relative risk rTPA Recombinant t
Page 32 and 33: Port catheter system: Subcutaneous
Page 34: Access recirculation: Resulting fro
Page 37 and 38: purpose unless it is implemented an
Page 39 and 40: In patients without diabetes, relat
Page 41 and 42: I. CLINICAL PRACTICE GUIDELINES FOR
Page 43 and 44: tion. In addition, counseling patie
Page 45 and 46: esonance angiography (MRA) may be u
Page 47 and 48: 2.1.5 While this order of access pr
Page 49 and 50: Vascular access infections in HD pa
Page 51 and 52: • Multiple insertion sites are av
Page 53 and 54: 2. Short-term catheter tips should
Page 55 and 56: tip(s) of the catheter should be in
Page 57 and 58: within our population, the multidis
Page 59 and 60: RATIONALE There is considerable evi
Page 61 and 62:
“trained, experienced dialysis nu
Page 63 and 64:
A needle with a back eye should alw
Page 65 and 66:
The Centers for Disease Control and
Page 67 and 68:
Figure 2. Cannulating a buttonhole.
Page 69 and 70:
4.3.1.2 Physical findings of persis
Page 71 and 72:
Asymptomatic, but hemodynamically s
Page 73 and 74:
Figure 4. IAPs within normal grafts
Page 75 and 76:
IAP differs according to access typ
Page 77 and 78:
with postintervention outcome for s
Page 79 and 80:
algorithm solves for access flow wi
Page 81 and 82:
Direct measurement of static pressu
Page 83 and 84:
measurements. However, even with id
Page 85 and 86:
288 CPGs for Vascular Access Nation
Page 87 and 88:
Page 89 and 90:
Attempts to combine the various sur
Page 91 and 92:
angioplasty if the stenosis is grea
Page 93 and 94:
abnormality in an access is so high
Page 95 and 96:
Page 97 and 98:
y the small sample size of the stud
Page 99 and 100:
GUIDELINE 5. TREATMENT OF FISTULA C
Page 101 and 102:
orders), make a digital photo map o
Page 103 and 104:
sonographic findings. In contrast t
Page 105 and 106:
Figure 8. Treatment of stenosis. (C
Page 107 and 108:
available. This leads to the astoni
Page 109 and 110:
In cases in which a physiological s
Page 111 and 112:
After angioplasty or surgical revis
Page 113 and 114:
Extremity edema persisting beyond 2
Page 115 and 116:
gioplasty alone. 382,459-461 Stents
Page 117 and 118:
GUIDELINE 7. PREVENTION AND TREATME
Page 119 and 120:
Early detection of access dysfuncti
Page 121 and 122:
Figure 9. Assessing dysfunction of
Page 123 and 124:
of 200 mL/min), tPA reconstituted a
Page 125 and 126:
Treatment of an Infected HD Cathete
Page 127 and 128:
Catheter exit-site infections alone
Page 129 and 130:
antibiotic locks were effective. 56
Page 131 and 132:
• Hemothorax • Hemomediastinum
Page 133 and 134:
initial success, ease of use, and p
Page 135 and 136:
The duration of effect after thromb
Page 137 and 138:
II. CLINICAL PRACTICE RECOMMENDATIO
Page 139 and 140:
CLINICAL PRACTICE RECOMMENDATIONS F
Page 141 and 142:
Page 143 and 144:
Page 145 and 146:
7.4.4 Short-term catheters should b
Page 147 and 148:
CLINICAL PRACTICE RECOMMENDATION 8:
Page 149 and 150:
Figure 11. Pediatric progress from
Page 151 and 152:
III. RESEARCH RECOMMENDATIONS PREAM
Page 153 and 154:
to therapy, and both short-term and
Page 155 and 156:
The use of diluted contrast to char
Page 157 and 158:
parameter that is less subjective a
Page 159 and 160:
What demographic variables influenc
Page 161 and 162:
WORK GROUP BIOGRAPHIES Anatole Besa
Page 163 and 164:
Surgical Society, and a fellow of t
Page 165 and 166:
27. Trerotola S: Interventional rad
Page 167 and 168:
79. Stonebridge PA, Edington D, Jen
Page 169 and 170:
130. Kaufman JL, Garb JL, Berman JA
Page 171 and 172:
178. Work J: Chronic catheter place
Page 173 and 174:
230. Peleman RA, Vogelaers D, Versc
Page 175 and 176:
282. Bacchini G, Cappello A, La Mil
Page 177 and 178:
334. Krivitski NM, Gantela S: Acces
Page 179 and 180:
385. Dember LM, Holmberg EF, Kaufma
Page 181 and 182:
435. Stevenson KB: Management of he
Page 183 and 184:
481. Trerotola SO, Vesely TM, Lund
Page 185 and 186:
528. Tranter SA, Donoghue J: Brushi
Page 187 and 188:
579. Lund GB, Trerotola SO, Scheel
Page 189 and 190:
629. Strippoli GF, Craig JC, Schena
Page 191 and 192:
APPENDIX 1. METHODS FOR EVALUATING
Page 193 and 194:
on these questions and topics, in a
Page 195 and 196:
Grading of Individual Studies Study
Page 197 and 198:
400 Appendix National Kidney Founda
Page 199 and 200:
of diagnostic tests.* Each test was
Page 201 and 202:
or not the studies were carried out
Page 203 and 204:
Ovid MEDLINE, Ovid MEDLINE Daily Up
Page 205 and 206:
VASCULAR ACCESS, UPDATE 2006 PEDIAT
Page 210:
Kidney Learning System (KLS) A Curr
show all

2006 Updates Clinical Practice Guidelines and Recommendations

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?